BRIGHTPLEX

Welcome to the Brand page for “BRIGHTPLEX”, which is offered here for Recorded software for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatment and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition;pharmaceutical preparations for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing diagnostic or identification information of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising biological markers, reagents and medical tests for diagnostic purposes, for testing biological tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis;medical analysis services, analysis of tumor, cancer or equivalent medical condition; medical assistance; health care services; medical therapeutic services; medical diagnostics, diagnostics in the field of medicine; genetic and tissue analysis services for medical purposes; medical testing services for the detection, quantification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis, analyzing the immune contexture of a tumor;research, development, technical design and scientific testing services in the field of oncology; industrial analysis and research services in the field of oncology; clinical trial services for others; tests in laboratories, analysis of biological mechanisms of actions, biomarkers and signatures for research in biology purposes; development of quality control testing methods for others; research, development, technical design, testing, consulting and analysis services in the field of immunology and oncology; research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the field of immune repertoire analysis and the genome; design and development of software in the field of biology;.

Its status is currently believed to be active. Its class is unavailable. “BRIGHTPLEX” is believed to be currently owned by “Veracyte”.